Latest Healthcare It News

EMVision Medical Devices has made significant strides in its emu™ bedside scanner pivotal trial and First Responder program, boosting FY26 revenue by 57% while trimming its net loss by 15%.

WAM Research’s FY2026 investment portfolio dropped 18%, dragging the company to a $28 million net loss. Despite underperformance, the LIC sustains its 10 cents per share dividend, backed by strong reserves and franking credits.

Regis Healthcare reported a robust FY26 with revenue hitting $1.35 billion, underpinned by strong occupancy and strategic acquisitions. The company is investing heavily in growth and digital transformation while navigating sector reforms and climate risks.

nib Group reported a 6.2% revenue increase to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26, despite a 5.9% net profit dip. The company achieved maiden profitability in Health Services and declared a fully franked 21c dividend including a 5c special, supported by ongoing Travel insurance divestments.

Ansell Limited (ASX:ANN) reported a robust FY26 with net profit doubling to US$208.6 million, driven by strong sales growth and operational resilience amid geopolitical challenges. The company also announced a leadership change and reaffirmed its sustainability ambitions.

Charter Hall Social Infrastructure REIT (ASX:CQE) posted a robust FY26 result with a 13.1% rise in operating earnings per unit, driven by strategic acquisitions and disciplined capital recycling. The portfolio now boasts a $2.3 billion valuation, near-full occupancy, and extended lease terms, underpinning income resilience amid ongoing sector demand.

Charter Hall Long WALE REIT (ASX:CLW) reported steady operating earnings growth and reinforced its long WALE portfolio quality for FY26, alongside a $2 billion debt refinancing and enhanced sustainability credentials.

Arena REIT reported an 8% rise in net operating profit to $79.1 million for FY2026, driven by rental growth and development completions, while facing uncertainty over its Edge Early Learning Portfolio due to rent defaults.

Pro Medicus' US arm, Visage Imaging, has landed a substantial 7-year, A$25 million contract to deploy its Visage 7 cloud-based imaging platform across Valley Health's hospital network in Virginia and West Virginia.

Fisher & Paykel Healthcare has raised its full-year net profit guidance for FY2027, buoyed by robust first-half sales and a $23 million US tariff refund. The medical devices maker forecasts up to 24% profit growth in H1, driven by hospital product demand and operational efficiencies.

Excite Technology Services (ASX: EXT) has secured $3.122 million in sales over June and July 2026, bolstered by government contracts and private sector recurring revenue. The company is also tapping into a growing AI cybersecurity market with a pipeline exceeding $200,000.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.